Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
12/01/1991 | CA2043385A1 Substituted oxadiazoles and thiadiazoles for use in the treatment of glaucoma and novel compounds having such use |
12/01/1991 | CA2043367A1 Dioxo-tetrahydroquinoline derivatives |
12/01/1991 | CA2042922A1 Anti-tumour compounds |
12/01/1991 | CA2042536A1 Method for preparing an antitumor dextran |
12/01/1991 | CA2042159A1 Method for preventing onset of restenosis after angioplasty employing an ace inhibitor |
12/01/1991 | CA2041951A1 Method for preventing onset of restenosis after angioplasty employing pravastatin |
11/30/1991 | WO1991018914A1 Synthesis of glycerol di- and triphosphate derivatives |
11/30/1991 | WO1991018596A1 Methods for treating inflammation and compounds and compositions suitable for use therein |
11/30/1991 | CA2083134A1 Methods for treating inflammation and compounds and compositions suitable for use therein |
11/30/1991 | CA2043424A1 Azole derivatives |
11/30/1991 | CA2043317A1 Oxazolidinones |
11/28/1991 | WO1991018089A1 Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
11/28/1991 | WO1991018027A2 Compounds |
11/28/1991 | WO1991018007A1 Phthalocyanatopolyethylene glycol, and phthalocyanato saccharides as fluorescent digoxin reagents |
11/28/1991 | WO1991018006A1 Fluorescent porphyrin, and fluorescent phthalocyanine - polyethylene glycol, polyol, and saccharide derivatives as fluorescent probes |
11/28/1991 | WO1991017997A1 PROCESS FOR THE PREPARATION OF 7α-ALKOXYCEPHEM DERIVATIVES |
11/28/1991 | WO1991017996A1 Cephalosporin esters which are useful as antibiotics |
11/28/1991 | WO1991017991A1 New sulfonyl compounds |
11/28/1991 | WO1991017985A1 Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds |
11/28/1991 | WO1991017980A1 Disulfide derivatives of mercaptoacylamino acids |
11/28/1991 | WO1991017973A1 5H-DIBENZO(a,d)CYCLOHEPTENES AS MUSCARINIC RECEPTOR ANTAGONISTS |
11/28/1991 | WO1991017774A1 Inclusion compounds of nimesulide with cyclodextrins |
11/28/1991 | WO1991017773A2 New protein-polycation conjugates |
11/28/1991 | WO1991017772A1 Controlled release dopamine and its use to stimulate nerve fiber growth |
11/28/1991 | WO1991017755A1 Compositions and methods for modulating rna activity through modification of the 5' cap structure of rna |
11/28/1991 | WO1991017754A1 Methods for treating and preventing inflammation of mucosa and blood vessels using fk 506 and related compounds |
11/28/1991 | WO1991017753A1 Bistriazenes as chemotherapeutic agents |
11/28/1991 | WO1991017751A1 Orally administrable gallium compositions and methods of treatment therewith |
11/28/1991 | WO1991017748A1 Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs |
11/28/1991 | WO1991017740A1 Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen |
11/28/1991 | WO1991017660A1 5,10-methylene-tetrahydrofolate as a modulator of a chemotherapeutic agent |
11/28/1991 | WO1991015204A3 Method and agents for the selective reduction of lp(a) |
11/28/1991 | WO1991014437A3 Use of copper(ii) containing compounds to accelerate wound healing |
11/28/1991 | WO1991013606A3 Use of 3,7-dimethyloctan-1-ol in cosmetic and dermatological preparations |
11/28/1991 | WO1991005754A3 Derivatives of long-chain fatty alcohols and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
11/28/1991 | DE4116659A1 Nimesulid inclusion cpds. with cyclodextrin - more water-soluble with improved bio-availability than nimesulid alone |
11/28/1991 | DE4016994A1 New anhydro-statin-phosphono:pyrrolidine(s) and -piperidine(s) - useful as antiviral cpds. in human and animal medicine, active against e.g. HIV |
11/28/1991 | DE4016941A1 Use of N-(aminoacyl) amino-acids and salts - dopaminergic and prolactin-reducing agent for treating disorders caused by reduced cerebral and peripheral circulation |
11/28/1991 | CA2083512A1 Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds |
11/27/1991 | EP0458751A1 Delivery system for cyclic amino acids with improved taste, texture and compressibility |
11/27/1991 | EP0458699A2 Use of baclofen for the preparation of medicaments for the treatment of angina pectoris |
11/27/1991 | EP0458697A1 N-substituted trifluoromethylphenyl tetrahydropyridines, process for their preparation, intermediates and pharmaceutical preparations containing them |
11/27/1991 | EP0458696A2 Use of 1-(2-naphthylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine for the preparation of medicaments for the treatment of cerebral and neuronal diseases |
11/27/1991 | EP0458661A1 Therapeutical application of histamine H3 receptor agonists, new compounds and their use for the preparation of medicaments |
11/27/1991 | EP0458643A2 Process for preparing an optically active cyclobutanone, an intermediate in the synthesis of an optically active cyclobutane nucleoside |
11/27/1991 | EP0458642A1 Amino bicyclic compounds |
11/27/1991 | EP0458641A2 Use of prostaglandin derivatives in the treatment of congestive heart failure |
11/27/1991 | EP0458640A2 Use of ergoline derivatives for the treatment of diseases associated with bone demineralization |
11/27/1991 | EP0458636A1 Antiemetic and migraine suppressing heterocyclic compounds and pharmaceutical compositions containing them |
11/27/1991 | EP0458618A1 6-Substituted purinyl piperazine derivatives |
11/27/1991 | EP0458590A1 Treatment of ocular hypertention with a synergistic combination |
11/27/1991 | EP0458589A1 Treatment of ocular hypertension with an ocular synergistic combination |
11/27/1991 | EP0458588A1 Treatment of ocular hypertension with a synergistic combination for ocular administration |
11/27/1991 | EP0458587A1 Synergistic combination for ophthalmic use |
11/27/1991 | EP0458551A1 Spiro-isoquinoline-pyrrolidines and analogs thereof useful as aldose reductase inhibitors |
11/27/1991 | EP0458549A1 N-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors |
11/27/1991 | EP0458519A2 Synthesis of nucleotide and nucleoside derivatives |
11/27/1991 | EP0458459A2 Substituted benzhydryl 2-hydroxypropyl piperazine derivatives |
11/27/1991 | EP0458387A1 Isochromane derivatives |
11/27/1991 | EP0458363A1 Fluorinated bis(hydroxymethyl) cyclobutyl purines and pyrimidines |
11/27/1991 | EP0458331A1 Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepines and related analogs, a process for their preparation and their use as medicaments |
11/27/1991 | EP0458287A2 Use of magnesium-pyridoxal-5'-phosphate-glutaminate for the prevention of diseases which result from vascular lesions |
11/27/1991 | EP0458259A2 Novel antibiotic and process for preparing the same |
11/27/1991 | EP0458234A2 3-[1,Thiazolidinylbutyl-4-piperazinyl]-1H-indazoles, a process for their preparation and their use as medicaments |
11/27/1991 | EP0458214A1 Bicyclic 1-azacycloalcanes |
11/27/1991 | EP0458207A2 Indole derivatives |
11/27/1991 | EP0458160A2 Substituted diphenylmethane derivatives as analgesic or anti-inflammatory agents |
11/27/1991 | EP0458079A2 Ultrasonic contrast agent, its preparation and application as diagnostic or therapeutic |
11/27/1991 | EP0458037A1 Bis-aryl amide and urea antagonists of platelet activating factor |
11/27/1991 | EP0457950A1 Use of stearidonic acid in the treatment of inflammatory disorders |
11/27/1991 | EP0457921A1 Novel platinum (ii) complex and drug for treating malignant tumor |
11/27/1991 | EP0457919A1 Functional food |
11/27/1991 | EP0457908A1 HYDROCHLORIDE 2,3,3a,4,5,6-HEXAHYDRO-8-CYCLOHEXYL-1H-PYRAZINO (3,2,1-j,k)CARBAZOL, METHOD OF OBTAINING IT AND A PHARMACEUTICAL PREPARATION OF ANTIDEPRESSIVE ACTION BASED ON IT |
11/27/1991 | EP0457803A1 4-hydroxythiazoles as 5-lipoxygenase inhibitors |
11/27/1991 | EP0349593B1 Method of producing high aqueous volume multilamellar vesicles |
11/27/1991 | EP0268616B1 Composition of matter containing potassium acetylsalicylate and useful for producing solutions of potassium acetylsalicylate, and process for preparation |
11/27/1991 | CN1056500A 3'-deamino-4'-deoxy-4'-amino-8-fluoroan-thracyclines and processes for their preparation |
11/27/1991 | CN1056499A Heterocyclic-nmda antagonists |
11/27/1991 | CN1056497A Neuroprotective indolone and related derivatives |
11/27/1991 | CN1056496A Improvements in and relating to ergoline-8-carboxamides |
11/27/1991 | CN1056495A Substituted 5-(2-(2-(2-aryl-2 hydroxyethyl) amino) propyl)-1,3-benzodioxoles |
11/27/1991 | CN1056494A Bis-aryl amide and urea antagonists of platelet activating factor |
11/27/1991 | CN1056487A Process for preparing 2,2-dimethyl-5-(2,5-dimethyl phenoxy) pentanoic acid |
11/27/1991 | CN1056427A Gene therapy for cell proliferative diseases |
11/27/1991 | CN1056426A Synergistic therapeutic composition and methods |
11/27/1991 | CN1056421A Protection from shock subsequent to injury by double-stranded rnas |
11/27/1991 | CN1056420A Process for preparing pharmaceutical composition containing 2-methoxy methyl penems |
11/27/1991 | CN1014895B Process for preparation of 4(3h)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d) pyrimidine derivatives |
11/27/1991 | CN1014891B Process for preparation of di-tert-butyl phenol compounds |
11/27/1991 | CN1014889B Process for preparation of diphenylethylene |
11/27/1991 | CN1014887B Process for preparation of amides, pharmacologically active compound |
11/27/1991 | CA2043216A1 Use of substituted .beta.-hydroxyethylamines as potent inhibitors of the exoenzymes of fungi |
11/27/1991 | CA2043143A1 Retrovirally active new anhydrostatin phosphonopyrrolidines and piperidines |
11/26/1991 | WO1991018888A1 N-substituted-1,2,4-triazolone compounds for treatment of cardiovascular disorders |
11/26/1991 | US5068458 Chemical process for halogenating 2-methyl-6-methoxynaphthalene |
11/26/1991 | US5068440 Process for the manufacture of N,N-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride monohydrate |
11/26/1991 | US5068412 (2R,3S,4S)-α-(carboxycyclopropyl)glycine |
11/26/1991 | US5068354 Cathepsin B inhibitors, enzyme inhibitors for muscular disorders |
11/26/1991 | US5068349 Mitomycin derivatives |
11/26/1991 | US5068340 Antagonist of platelet activating factor for treatment of asthma, inflammation or shock |